Katarzyna Bogucka-Janczi

3PUBLICATIONS
3CO-AUTHORS
Medical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 14, 2023
ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization.

Katarzyna Bogucka-Janczi, Gregory Harms, Marie-May Coissieux

|Nov 10, 2020
Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.

Katarzyna Bogucka, Federico Marini, Sebastian Rosigkeit

|Oct 18, 2020
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.

Katarzyna Bogucka, Federico Marini, Sebastian Rosigkeit

Pageof 1